Both glycerol and fatty-acid release can be quantified in adipocytes or ex vivo adipose tissue, but measured values are affected by reuptake, re-esterification, substrate binding, sampling time, and nonlinear accumulation
Human safety data is limited, and long-term effects remain unknown
The most common autoimmune disease (Hashimotos thyroiditis) sometimes accompanies the diagnosis of Ulcerative colitis, including gut dysbiosis, which doesnt necessarily mean outright SIBO or SIFO-to make this distinction clear
I fully agree that innovation in longevity medicine is important, but I wonder whether experimentation outside controlled research settings could put individuals at unnecessary risk
The products exist in a space where they are legal to sell as supplements but lack regulatory blessing for therapeutic use
The systemic distribution means effects spread throughout the body rather than concentrating in any single area